These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10691820)
41. Management of superficial bladder cancer in Victoria: 1990 and 1995. Frydenberg M; Millar JL; Toner G; Bolton D; Syme R; Thursfield VJ; Giles GG; ANZ J Surg; 2005 May; 75(5):270-4. PubMed ID: 15932435 [TBL] [Abstract][Full Text] [Related]
42. Follow-up of patients with noninvasive and superficially invasive bladder cancer. Holmäng S Semin Urol Oncol; 2000 Nov; 18(4):273-9. PubMed ID: 11101090 [TBL] [Abstract][Full Text] [Related]
43. The biology and treatment of superficial bladder cancer. Torti FM; Lum BL J Clin Oncol; 1984 May; 2(5):505-31. PubMed ID: 6427417 [TBL] [Abstract][Full Text] [Related]
44. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer. Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912 [TBL] [Abstract][Full Text] [Related]
45. Diagnosis and treatment of bladder cancer. Sharma S; Ksheersagar P; Sharma P Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342 [TBL] [Abstract][Full Text] [Related]
46. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971 [TBL] [Abstract][Full Text] [Related]
47. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy. Hedelin H; Jonsson K; Salomonsson K; Boman H Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052 [TBL] [Abstract][Full Text] [Related]
48. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153 [TBL] [Abstract][Full Text] [Related]
49. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related]
50. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! Jichlinski P; Leisinger HJ Urol Int; 2005; 74(2):97-101. PubMed ID: 15756058 [TBL] [Abstract][Full Text] [Related]
51. Unsuspected bladder carcinoma in patients undergoing radical prostatectomy. Kim ED; Ignatoff JM J Urol; 1994 Aug; 152(2 Pt 1):397-400. PubMed ID: 8015079 [TBL] [Abstract][Full Text] [Related]
52. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking. Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM; BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434 [TBL] [Abstract][Full Text] [Related]
53. Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers-a Prospective Double-Blind Clinical Study. Mariappan P; Lavin V; Phua CQ; Khan SAA; Donat R; Smith G Urology; 2017 Nov; 109():134-139. PubMed ID: 28818537 [TBL] [Abstract][Full Text] [Related]